Mechanisms of Atrial Pathoelectrophysiology in HCM

✅ This trial is currently recruiting volunteers

If you think you might be eligible, speak to your GP or specialist about this trial before applying.

Status

Recruiting

Phase

N/A

Participants

ALL

Age Range

18 Years – 80 Years

About This Trial

This study aims to learn why atrial fibrillation (AF), a type of irregular heartbeat, happens more often and is harder to treat in people with hypertrophic cardiomyopathy (HCM). HCM is an inherited condition where the heart muscle is thicker than usual.

Researchers will study electrical signals from the heart and advanced heart imaging. By doing this, they hope to better understand how AF behaves in people with HCM and why treatments may not work as well for them.

The information from this study may help improve future treatments for people who have both HCM and AF.

Who Can Join?

Inclusion Criteria: * Paroxysmal or persistent atrial fibrillation * Diagnosis of hypertrophic cardiomyopathy * Patient planning to proceed to atrial fibrillation ablation following clinical consultation * Age 18-80 years * Able and willing to provide written informed consent * Able and willing to comply with study follow up requirements Exclusion Criteria: * Any clinical contra-indication to ablation * Any disease limiting life expectancy to

View Full Trial Details ↗

⚠ Always speak to your doctor before applying to any clinical trial.